Q32 Bio (QTTB) Cash from Operations (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.64% |
| Dec 31, 2025 | -46.10% |
| Sep 30, 2025 | 60.29% |
| Jun 30, 2025 | 14.67% |
| Mar 31, 2025 | -9.22% |
| Dec 31, 2024 | 41.46% |
| Sep 30, 2024 | 12.12% |
| Jun 30, 2024 | -52.66% |
| Mar 31, 2024 | -35.80% |
| Dec 31, 2023 | -167.39% |
| Sep 30, 2023 | 239.89% |
| Jun 30, 2023 | 9.03% |
| Mar 31, 2023 | 54.06% |
| Dec 31, 2022 | -9.09% |
| Sep 30, 2022 | 19.17% |
| Jun 30, 2022 | -0.53% |
| Mar 31, 2022 | -0.83% |
| Dec 31, 2021 | -19.86% |
| Sep 30, 2021 | -5.29% |
| Jun 30, 2021 | 19.15% |
| Mar 31, 2021 | -156.83% |
| Dec 31, 2020 | 59.80% |
| Sep 30, 2020 | -3.22% |
| Jun 30, 2020 | -8.28% |
| Mar 31, 2020 | 1.85% |
| Dec 31, 2019 | -3.33% |
| Sep 30, 2019 | -17.60% |
| Jun 30, 2019 | -21.26% |
| Mar 31, 2019 | -121.20% |
| Dec 31, 2018 | 40.99% |
| Sep 30, 2018 | -40.47% |
| Jun 30, 2018 | 11.74% |
| Mar 31, 2018 | -150.09% |
| Dec 31, 2017 | 504.63% |
| Sep 30, 2017 | 2.62% |
| Jun 30, 2017 | -23.66% |